Abstract
Treatment Intensity, Timing of Relapse and Outcome of 713 Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) in a Population-Based Setting in Sweden
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have